Among the developmental and/or exacerbating factors of IgA nephropathy, cytokines have been found to play a role in the progression of the disease. We previously reported that the levels of urinary IL-6, monocyte chemoattractant protein (MCP)-1, and IL-8 in patients in the advanced stage of IgA nephropathy were significantly higher than those in patients in the mild stage of this disease. It appears that measurement of urinary cytokines and/or chemokines is useful in evaluating the degree of renal injuries in patients with IgA nephropathy. Although one of the most critical findings in patients with IgA nephropathy is glomerular mesangial deposition of IgA (mainly IgA1), it is still unknown whether the activation of mesangial cells is directly triggered by IgA per se. Fc alpha receptor (FcαR) is one of the receptors for binding of IgA in various cells, and displays various immunological responses on binding. It is important to analyze the mesangial functions in the production of MCP-1 via FcαR in the pathogenesis of IgA nephropathy. To assess biological functions of FcαR in the mesangial cells, we established mesangial transfectants which expressed the FcαR and FcRγ chains. Murine mesangial cell lines (SV40 MES 13) were transfected with cDNA of human FcαR. Furthermore, we cotransfected some of the FcαR transfectants with cDNA of the human FcRγ chain, which is known as a common signaling molecule of Fc receptors. MCP-1 from each transfectant stimulated with heat aggregated IgA was assayed by sandwich enzyme-linked immunosorbent assay (ELISA). The secretion of MCP-1 was elicited in a dose-dependent manner by stimulation with aggregated IgA in FcαR with or without the FcRγ chain (Fγ/F cells). It is considered that glomerular mesangial cells might produce MCP-1 by cell-activation with FcαR cross-linking after incubation with aggregated IgA. It appears that the activation mechanism of mesangial cells was efficiently controlled by association with the FcRγ chain, and that FcαR with the FcRγ chain may contribute to mesangial response to IgA deposition.
INTRODUCTION
IgA nephropathy is widely recognized as one of the most common primary glomerulonephritides, and is a distinct clinicopathologic entity originally described by Berger (1) . IgA nephropathy is characterized by glomerular mesangial deposition of IgA (mainly IgA1) in renal biopsy specimens as determined by immunohistochemistry and is generally considered to be an immunecomplex-mediated glomerulonephritis. Thus, IgA nephropathy is defined as nephropathy showing proliferative changes in the glomerular mesangial cells and increases in the mesangial matrices associated with deposition of IgA. When Berger first reported IgA nephropathy, prognosis of this disease was generally benign (1) . However, almost 40% of patients with IgA nephropathy have progressed to end-stage renal failure (ESRF) during 20 years of observation. Several developmental and/or exacerbating factors for patients with IgA nephropathy have been reported. Among them, cytokines have been found to play a role in the pathogenesis and/or development of IgA nephropathy. It has been found that a variety of cytokines such as platelet derived growth factor (PDGF), IL-1, insulin-like growth factor (IGF-1) and IL-6 act as growth factors for glomerular mesangial cells. Although one of the most critical findings in patients with IgA nephropathy is glomerular mesangial deposition of IgA (mainly IgA1), it is still unknown whether the activation of mesangial cells is directly triggered by IgA per se.
The objective of the present review is to summarize the relationship between roles of cytokine mediators from mesangial cells and progression of renal injuries in 
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patients with IgA nephropathy.
Histopathology of patients with IgA nephropathy
Histopathologically, IgA nephropathy is characterized by thickening of glomerular mesangial matrix with mesangial cell proliferation. Glomerular lesions as observed by light microscopy are variable, and have been classified as follows: minimal lesions, focal glomerulonephritis, diffuse mesangial proliferative g l o m e r u l o n e p h r i t i s , a n d d i ff u s e s c l e r o s i n g glomerulonephritis. Glomerular periodic acid-Schiff (PAS)-positive deposits are identified in the mesangial areas. Paramesangial deposits (so-called "hemispherical bodies") have frequently been observed in patients with IgA nephropathy and are therefore regarded as one of the parameters of this disease ( Fig. 1 ). Glomerular sclerosis, tubular atrophy and fibrosis in the interstitium are observed in the ESRF in patients with IgA nephropathy (Fig. 2 ).
Glomeruli typically contain generalized-diffuse granular mesangial deposits of IgA and C3 (Fig. 3A,B ). IgA (IgA1) is the predominant class of immunoglobulin noted in glomeruli. Most glomeruli contain deposits of IgG, IgM and fibrinogen. Granular depositions of IgA and/or IgM and IgG are mainly observed in the glomerular mesangial areas and sometimes observed in the capillary walls. Electron-dense deposits are usually observed in the glomerular mesangial areas and sometimes in the glomerular basement membranes (GBM) ( Fig. 4 ). 
CYTOKINE PRODUCTION IN GLOMERULI AND TUBULAR EPITHELIAL CELLS
A variety of cell types, including endothelial cells, mesangial cells and monocytes, produce monocyte chemoattractant protein (MCP)-1 in response to inflammatory signals, including cytokines (IL-1, TNF-α and INF-γ) and immune-complexes. Induction of cytokine production by glomerular mesangial or tubular cells in vitro is shown in tables 1 and 2, respectively (2) . After incubation of TNF-α or IL-1α in human tubular epithelial cells, expression and/or production of MCP-1 are observed. Van Es (2) showed a glomerular capillary loop demonstrating local cytokine production by recruited monocytes, mesangial cells (MesC), endothelial cells (EndC), and glomerular epithelial cells (GEC) (2) . After the deposition of polymeric IgA in the glomerular mesangial cells, several cytokines, i.e. MCP-1, RANTES, IL-6, IL-8 and PDGF, might be secreted from such cells. Podocytes may also produce MCP-1, IL-6 and IL-8. Extracellular matrix components (ECM) such as Type 1 collagen, fibronectin, laminin and heparan sulfate proteoglycan (HSPG) were produced by the mesangial cells ( Fig. 5 ).
C Y TO K I N E S I N S E RU M A N D URINARY SAMPLES OF PATIENTS WITH IgA NEPHROPATHY
In 1989 and 1991, the authors reported a significant correlation between the levels of serum IL-2R or urinary IL-6 and disease activities, i.e. levels of urinary protein, urinary casts, blood urea nitrogen (BUN) and uric acid, Gomez-Guerrero C, Gonzalez E, Egido J. Evidence for a specific IgA receptor in rat and human mesangial cells. J Immunol 1994; 151:7172-7181.
Gomez in patients with IgA nephropathy (3, 4) . The levels of serum IL-2R or urinary IL-6 in patients with advanced stage of IgA nephropathy were significantly higher than those in patients with the mild stage of this disease or in healthy adults. It appears that the measurement of serum IL-2R and/or urinary IL-6 is useful in evaluating the degree of glomerular injuries and/or prognosis in patients with IgA nephropathy (3, 4) . Saitoh et al (5) also reported the relationship between urinary levels of MCP-1 and disease activity in patients with IgA nephropathy. The levels of MCP-1 in the advanced stage of IgA nephropathy were significantly higher than those in the mild stage and healthy controls (Fig. 6 ). It appears that the increase of urinary MCP-1 might be due to secretion of glomerular mesangial cells and/or tubular epithelial cells in patients with advanced stage of IgA nephropathy (5) . Recently, the authors showed a positive correlation between the levels of urinary IL-8 and the disease activity, i.e. heavy proteinuria and presence of urinary casts (6) . A significant correlation between the levels of urinary IL-8 and tubular dysfunction was also found in patients with IgA nephropathy. It is suggested that the measurement of urinary IL-8 might be useful in evaluating the degree of glomerular and tubular injuries in this disease (6) .
INTERACTION OF IgA DEPOSITS AND MCP-1 PRODUCTION IN GLOMERULAR MESANGIAL CELLS
Although one of the most critical findings in patients with IgA nephropathy is glomerular mesangial deposition of IgA , mainly IgA1, it is still unknown whether the activation of mesangial cells is directly triggered by IgA per se. After IgA binding to the Fcα receptor (R) α chain, physical association of α chain and γ chain, and then signal transduction occurs. Immunological responses, such as clearance of IgA immune-complexes, cytokine/ chemokine production, superoxide generation and antibody-dependent cellular cytotoxicity (ADCC) take place as shown in figure 7 . Recently, we examined the accumulation of immunoglobulins (IgG, IgM, IgA) and complement (C3) in the glomerular mesangial areas of γ chain knock-out mice. IgA accumulated in the mesangial areas in 52-week-old γ knock-out mice, but IgA was not accumulated in such areas in age-matched wild type mice. Electron dense deposits were observed in the mesangial areas in 52-week-old knock-out mice. However, mesangial cell proliferation and cell infiltration were not observed in glomeruli by PAS staining. Slight mesangial expansion was observed. It appears that accumulated IgA, IgG and IgM without γ chain expression may not enhance glomerular inflammatory changes (Suzuki et al in preparation for submission). Thus, the γ chain may play an important role in the signal transduction. FcαR is one of the receptors for binding of IgA in various cells, and displays various immunological responses on binding. There is controversy as to whether FcαR is expressed on glomerular mesangial cells. It is important to analyze the mesangial functions in the production of MCP-1 via FcαR in the pathogenesis of IgA nephropathy. Table 3 shows positive reports of Fcα receptor expression of the glomerular mesangial cells (7) (8) (9) (10) . Three papers did not report FcαR expression of the mesangial cells (11) (12) (13) (Table 4 ). Recently, Professor Lai's group (13) We established mesangial transfectants, which expressed the FcαR and Fcγ chains to assess biological functions of FcαR in the mesangial cells (submitted). Murine mesangial cell lines (SV40 MES 13) were transfected with cDNA of human FcαR. We cotransfected some of the FcαR transfectants with cDNA of the human FcRγ chain,which is known as a common signaling molecule of FcRs. Two kinds of mesangial transfectants that stably expressed human FcαR with or without the FcRγ chain (Fγ/F cells) were generated. The tyrosine phosphorylation of intramesangial proteins in FcαR cross-linking was examined by immunoprecipitation. The amounts of MCP-1 from each transfectant stimulated with heat aggregated IgA were determined by sandwich ELISA. Expression of the FcαRα chain on the transfectants was detected by FACS scanning. MCP-1 production by transfected mesangial cells is shown in figure 8 . A high dose of aggregated IgA (200 µg/mL) induced a significant elevation of MCP-1 production in the Fγ and F cells. The production of MCP-1 in Fγ cells was significantly higher than that in F cells. The findings of this study are summarized as follows: 1. Phosphorylation of the FcRγ chain and syk kinase was detected in Fγ and F cells, but not in untransfected cells. 2. The dose-dependent manner secretion of MCP-1 was elicited by stimulation with aggregated IgA in Fγ and F cells. 3. MCP-1 secretion in Fγ cells was significantly higher than that in F cells. Interestingly, more MCP-1 was produced from F cells under stimulation than from untransfected cells.
It is speculated that the physical association of FcαRα and FcRγ chains of native mesangial cells might induce production of MCP-1.
CONCLUSION
The measurement of urinary cytokines (IL-6, IL-8) and/ or chemokine (MCP-1) is useful in evaluating the degree of renal injuries in patients with IgA nephropathy. We concluded that glomerular mesangial cells might produce MCP-1 by cell-activation with FcαR cross-linking after incubation with aggregated IgA. It appears that the activation mechanism of mesangial cells was efficiently controlled by association with the FcRγ chain, and that FcαR with the FcRγ chain may contribute to the mesangial response to IgA deposition.
